{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:58:51Z","timestamp":1783072731113,"version":"3.54.6"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Jeanne-et-Jean-Louis-Levesque perinatal research Chair"},{"name":"Jean-Louis-L\u00e9vesque Foundation, Montr\u00e9al, QC"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jogc.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jogc.2017.11.032","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T11:26:02Z","timestamp":1533900362000},"page":"1044-1049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["First Trimester Screening for Fetal Aneuploidies Using Placental Growth Factor: The Great Obstetrical Syndrome (GOS) Study"],"prefix":"10.1016","volume":"40","author":[{"given":"Am\u00e9lie","family":"Boutin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Demers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Gasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Gigu\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"T\u00e9tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Laforest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Bujold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2017.11.032_bib0010","series-title":"Congenital anomalies in Canada 2013: a perinatal health surveillance report","author":"Public Health Agency of Canada","year":"2013"},{"key":"10.1016\/j.jogc.2017.11.032_bib0015","series-title":"Deaths from congenital anomalies in Canada, 1974 to 2012","first-page":"1","author":"Navaneelan","year":"2016"},{"key":"10.1016\/j.jogc.2017.11.032_bib0020","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1542\/peds.2010-1824","article-title":"Survival and morbidity outcomes for very low birth weight infants with Down syndrome","volume":"126","author":"Boghossian","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.jogc.2017.11.032_bib0025","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/ejhg.2008.122","article-title":"Twenty-year trends in prevalence and survival of Down syndrome","volume":"16","author":"Irving","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jogc.2017.11.032_bib0030","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jama.2016.9819","article-title":"Survival and surgical interventions for children with trisomy 13 and 18","volume":"316","author":"Nelson","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jogc.2017.11.032_bib0035","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ajmg.a.37495","article-title":"Survival of children with trisomy 13 and trisomy 18: a multi-state population-based study","volume":"170A","author":"Meyer","year":"2016","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jogc.2017.11.032_bib0040","series-title":"Birth defects. report by the secretariat. sixty-third world health assembly, 2010","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.jogc.2017.11.032_bib0045","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S1701-2163(16)34961-1","article-title":"Prenatal screening for fetal aneuploidy in singleton pregnancies","volume":"33","author":"Chitayat","year":"2011","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2017.11.032_bib0050","series-title":"Fetal anomaly screening programme: programme handbook","author":"NHS","year":"2015"},{"key":"10.1016\/j.jogc.2017.11.032_bib0055","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1097\/AOG.0000000000001406","article-title":"Practice bulletin no. 163: screening for fetal aneuploidy","volume":"127","author":"Committee on Practice Bulletins\u2014Obstetrics, Committee on Genetics, Society for Maternal-Fetal Medicine","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.11.032_bib0060","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1311037","article-title":"DNA sequencing versus standard prenatal aneuploidy screening","volume":"370","author":"Bianchi","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogc.2017.11.032_bib0065","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa1407349","article-title":"Cell-free DNA analysis for noninvasive examination of trisomy","volume":"372","author":"Norton","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogc.2017.11.032_bib0070","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1095\/biolreprod60.4.887","article-title":"Signal transduction and biological function of placenta growth factor in primary human trophoblast","volume":"60","author":"Desai","year":"1999","journal-title":"Biol Reprod"},{"key":"10.1016\/j.jogc.2017.11.032_bib0075","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/pd.2496","article-title":"First trimester maternal serum placental growth factor in trisomy 21 pregnancies","volume":"30","author":"Cowans","year":"2010","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2017.11.032_bib0080","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/pd.4597","article-title":"First trimester screening for Down syndrome using nuchal translucency, maternal serum pregnancy-associated plasma protein A, free-beta human chorionic gonadotrophin, placental growth factor, and alpha-fetoprotein","volume":"35","author":"Huang","year":"2015","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2017.11.032_bib0085","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/uog.6331","article-title":"Maternal serum placental growth factor at 11\u201313 weeks in chromosomally abnormal pregnancies","volume":"33","author":"Zaragoza","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.11.032_bib0090","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/(SICI)1097-0223(199806)18:6<537::AID-PD288>3.0.CO;2-Q","article-title":"Prenatal screening in the first trimester of pregnancy","volume":"18","author":"Wheeler","year":"1998","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2017.11.032_bib0095","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1471-0528.1996.tb09552.x","article-title":"Serum parameters and nuchal translucency in first trimester screening for fetal chromosomal abnormalities","volume":"103","author":"Zimmermann","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jogc.2017.11.032_bib0100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/07853899409147323","article-title":"First trimester biochemical screening for Down's syndrome","volume":"26","author":"Wald","year":"1994","journal-title":"Ann Med"},{"key":"10.1016\/j.jogc.2017.11.032_bib0105","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/(SICI)1097-0223(199709)17:9<821::AID-PD154>3.0.CO;2-5","article-title":"Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome","volume":"17","author":"Wald","year":"1997","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2017.11.032_bib0110","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1056\/NEJM199804023381404","article-title":"Screening of maternal serum for fetal Down's syndrome in the first trimester","volume":"338","author":"Haddow","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogc.2017.11.032_bib0115","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","article-title":"Presence of fetal DNA in maternal plasma and serum","volume":"350","author":"Lo","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2017.11.032_bib0120","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/pd.647","article-title":"Increased total cell-free DNA in the serum of pregnant women carrying a fetus affected by trisomy 21","volume":"23","author":"Spencer","year":"2003","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2017.11.032_bib0125","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/pd.3993","article-title":"Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci","volume":"32","author":"Zimmermann","year":"2012","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2017.11.032_bib0130","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/pd.4156","article-title":"The role of noninvasive prenatal testing as a diagnostic versus a screening tool: a cost-effectiveness analysis","volume":"33","author":"Ohno","year":"2013","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2017.11.032_bib0135","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/pd.4719","article-title":"Current controversies in prenatal diagnosis 3: is there still a value in a nuchal translucency screening ultrasound in conjunction with maternal plasma non-invasive cell-free DNA testing?","volume":"36","author":"Wilson","year":"2016","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2017.11.032_bib0140","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11\u201313 weeks gestation","volume":"214","author":"O'Gorman","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.11.032_bib0145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000341264","article-title":"Competing risks model in early screening for preeclampsia by biophysical and biochemical markers","volume":"33","author":"Akolekar","year":"2013","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.jogc.2017.11.032_bib0150","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.11.032_bib0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.11.032_bib0160","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216317310125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216317310125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T01:06:27Z","timestamp":1735088787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216317310125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1701216317310125"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2017.11.032","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First Trimester Screening for Fetal Aneuploidies Using Placental Growth Factor: The Great Obstetrical Syndrome (GOS) Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2017.11.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}